Ubiquitin ligase inhibitors and methods related thereto
US7659277B2 · kind B2 · utility
1Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2006 |
| Grant date | Feb 9, 2010 |
| Priority date | — |
| Expiry date | Jan 11, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses compounds that inhibit ubiquitin ligase activity. The application further discloses antiviral compounds, anticancer compounds, and compounds useful for the treatment of neurological disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.